Vasopeptidase inhibitors to treat isolated systolic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/00 (2006.01) A61K 31/55 (2006.01) A61K 31/554 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2405496

Vasopeptidase inhibitors especially omapatrilat, are useful in treating isolated systolic hypertension. The vasopeptidase inhibitor may be used in combination with other pharmaceutically active agents.

L'invention porte sur des inhibiteurs de vasopeptidase, notamment l'inhibiteur omapatrilat, qui sont utiles dans le traitement de l'hypertension systolique isolée. L'inhibiteur de vasopeptidase peut être utilisé en combinaison avec d'autres agents actifs d'un point de vue pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vasopeptidase inhibitors to treat isolated systolic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vasopeptidase inhibitors to treat isolated systolic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasopeptidase inhibitors to treat isolated systolic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1889480

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.